NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球 ELI 現貨和氟現貨分析市場:到 2028 年的行業趨勢和預測

Global ELISpot and FluoroSpot assay Market - Industry Trends and Forecast to 2028

出版商 Data Bridge Market Research Private Limited 商品編碼 1024325
出版日期 內容資訊 英文 292 Pages
商品交期: 3-5個工作天內
價格
全球 ELI 現貨和氟現貨分析市場:到 2028 年的行業趨勢和預測 Global ELISpot and FluoroSpot assay Market - Industry Trends and Forecast to 2028
出版日期: 2021年07月01日內容資訊: 英文 292 Pages
簡介

預計全球 ELI Spot 和 Fluoro Spot 檢測市場在 2021-2028 年的預測期內將錄得 12.7% 的顯著複合年增長率。

本報告探討了全球 ELI Spot 和 FluoroSpot 檢測市場、市場概況、市場增長和限制因素分析、市場機遇、挑戰、關鍵地區的監管趨勢以及新型冠狀病毒感染 (COVID-19)。市場影響、產品類型、來源、疾病、應用、最終用戶、分銷渠道、區域市場趨勢和預測、競爭條件、主要公司簡介等。

目錄

第 1 章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章五力分析

第 6 章PESTEL分析

第 7 章全球 ELI 現貨和氟現貨檢測市場:法規

  • 美國法規
  • 歐洲法規
  • 中國法規
  • 日本規定
  • 印度法規

第 8 章市場概覽

  • 促進因素
    • 慢性病發病率增加
    • 疾病及時診斷意識高漲
    • 增加了 FluoroSpot 檢測的實施
    • 使用疫苗研究試劑盒克服耐藥性
    • 在臨床試驗中使用 ELI Spot 和 Fluoro Spot 檢測
  • 抑制因素
    • ELI Spot 和 Fluoro Spot 檢測試劑盒的成本增加
    • 替代檢測試劑盒的可用性
    • 高質量檢測試劑的可用性低
    • ELI 點和氟點檢測的複雜性
  • 市場機會
    • 市場准入公司的戰略舉措
    • 體外診斷測試數量增加
    • 醫療費用增加
    • 增加研發
  • 挑戰
    • 嚴格的規章制度
    • 進行診斷測試的操作障礙
    • 企業間競爭加劇

第 9 章新型冠狀病毒感染 (COVID-19) 對 ELI 現貨和氟現貨檢測市場的影響

  • 對價格的影響
  • 對需求的影響
  • 對供應鏈的影響
  • 製造商的戰略決策
  • 結論

第 10 章全球 ELI 現貨和氟現貨分析市場:按產品類型

  • 概述
  • 檢測試劑盒
    • T 細胞檢測
    • B 細胞檢測
  • 補充/輔助產品
  • 分析器

第 11 章全球 ELI 現貨和氟現貨分析市場:按來源

  • 概述
  • 人類
  • 鼠標
  • 猴子
  • 其他

第 12 章全球 ELI 現貨和氟現貨檢測市場:按疾病分類

  • 概述
  • 傳染病
    • 流感
    • 愛滋病毒
    • 新型冠狀病毒感染 (COVID-19)
    • 其他
  • 癌症
  • 自身免疫性疾病
  • 過敏
  • 其他

第 13 章全球 ELI 現貨和氟現貨分析市場:按應用

  • 概述
  • 診斷應用
    • 傳染病
    • 移植
    • 其他
  • 調查申請
    • 臨床試驗
    • 癌症調查
    • 疫苗開發
    • 其他

第 14 章全球 ELI 現貨和氟現貨分析市場:最終用戶

  • 概述
  • 醫院/臨床實驗室
  • 調查
  • 生物製藥公司
  • 其他

第 15 章全球 ELI 現貨和氟現貨分析市場:按分銷渠道

  • 概述
  • 零售額
  • 直接出價

第 16 章全球 ELI 現貨和氟現貨分析市場:按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 中東/非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 埃及
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 新加坡
    • 馬來西亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 荷蘭
    • 瑞士
    • 俄羅斯
    • 比利時
    • 土耳其
    • 其他

第 17 章公司情況

  • 公司股票分析:世界
  • 公司份額分析:北美
  • 公司份額分析:歐洲
  • 企業股票分析:亞太地區

第 18 章SWOT分析

第 19 章公司簡介

  • BD
  • OXFORD IMMUNOTEC USA, INC.(A SUBSIDIARY OF PERKINELMER INC.)
  • R&D SYSTEMS, INC.
  • MABTECH
  • THERMO FISHER SCIENTIFIC INC.
  • ABCAM PLC
  • AUTOIMMUN DIAGNOSTIKA GMBH
  • CELLCARTA
  • CELLULAR TECHNOLOGY LIMITED(CTL)
  • COVANCE INC.(A SUBSIDIARY OF LABCORP DRUG DEVELOPMENT)
  • COVALAB, INC.
  • DIACLONE SAS
  • MIKROGEN GMBH
  • OXFORD BIOSYSTEMS LTD.
  • U-CYTECH

第 20 章問卷

第 21 章相關報導

目錄

Global ELISpot and FluoroSpot Assay Market is projected to register a substantial CAGR of 12.7% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation:

Global ELISpot and FluoroSpot Assay Market, By Product type (Assay Kits, Supplementary/ Ancillary Products and Analyzers), Source (Human, Mouse, Monkey and Others), Diseases (Infectious Diseases, Cancer, Autoimmune Diseases, Allergy and Others) Application (Diagnostic Application, Research Applications), End User (Hospitals & Clinical Laboratories, Research Institutes, Biopharmaceutical Companies and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland's, Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of Middle East and Africa) - Industry Trends and Forecast -2028.

Some of the major factors contributing to the growth of the global ELISpot and FluoroSpot Assay market are:

Increased Incidence of Chronic Diseases.

Surge in awareness about the timely diagnosis of the diseases.

Increased implementation of FluoroSpot assay.

Market Players:

The key market players for global ELISpot and FluoroSpot Assay market are listed below:

Thermo Fisher Scientific Inc.

BD

Mabtech

Cellular Technology Limited

CellCarta

DIACLONE SAS

Autoimmun Diagnostika GmbH

Oxford Biosystems

Oxford Immunotec USA, Inc.

U-CyTech

MIKROGEN DIAGNOSTIK

Bio-Connect Diagnostics B.V

Covance Inc.

Abcam plc.

R & D Systems, Inc.

TABLE OF CONTENTS

1 INTRODUCTION 32

  • 1.1 OBJECTIVES OF THE STUDY 32
  • 1.2 MARKET DEFINITION 32
  • 1.3 OVERVIEW OF GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET 32
  • 1.4 LIMITATIONS 33
  • 1.5 MARKETS COVERED 34

2 MARKET SEGMENTATION 36

  • 2.1 MARKETS COVERED 36
  • 2.2 GEOGRAPHICAL SCOPE 37
  • 2.3 YEARS CONSIDERED FOR THE STUDY 38
  • 2.4 CURRENCY AND PRICING 38
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 39
  • 2.6 MULTIVARIATE MODELLING 42
  • 2.7 TYPE LIFELINE CURVE 42
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 43
  • 2.9 DBMR MARKET POSITION GRID 44
  • 2.10 MARKET APPLICATION COVERAGE GRID 45
  • 2.11 VENDOR SHARE ANALYSIS 46
  • 2.12 SECONDARY SOURCES 47
  • 2.13 ASSUMPTIONS 47

3 EXECUTIVE SUMMARY 48

4 PREMIUM INSIGHTS 50

5 PORTERS FIVES FORCES 53

6 PESTEL ANALYSIS 54

7 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: REGULATIONS 55

  • 7.1 REGULATION IN THE U.S. 55
  • 7.2 REGULATION IN EUROPE: 56
  • 7.3 REGULATIONS IN CHINA 56
  • 7.4 MEDICAL DEVICE INSTRUCTIONS: 56
  • 7.5 REGULATIONS IN JAPAN 57
  • 7.6 REGULATION IN INDIA 57

8 MARKET OVERVIEW 58

  • 8.1 DRIVERS 60
    • 8.1.1 INCREASED INCIDENCE OF CHRONIC DISEASES 60
    • 8.1.2 SURGE IN AWARENESS ABOUT THE TIMELY DIAGNOSIS OF THE DISEASE 62
    • 8.1.3 INCREASED IMPLEMENTATION OF FLUOROSPOT ASSAY 62
    • 8.1.4 USE OF KITS FOR VACCINE RESEARCH TO OVERCOME THE DRUG RESISTANCE 63
    • 8.1.5 USE OF ELISPOT AND FLUOROSPOT ASSAY FOR CLINICAL TRIALS 63
  • 8.2 RESTRAINTS 64
    • 8.2.1 RISE IN COST OF THE ELISPOT AND FLUOROSPOT DETECTION KITS 64
    • 8.2.2 AVAILABILITY OF ALTERNATE DETECTION KITS 64
    • 8.2.3 LESS AVAILABILITY OF HIGH-QUALITY DETECTION REAGENTS 65
    • 8.2.4 COMPLEXITY IN ELISPOT AND FLUOROSPOT ASSAY 65
  • 8.3 OPPORTUNITIES 65
    • 8.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS 65
    • 8.3.2 RISING NUMBER OF IN-VITRO DIAGNOSTIC TESTS 66
    • 8.3.3 RISING HEALTHCARE EXPENDITURE 66
    • 8.3.4 INCREASING RESEARCH AND DEVELOPMENT 67
  • 8.4 CHALLENGES 68
    • 8.4.1 STRINGENT RULES & REGULATIONS 68
    • 8.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS 69
    • 8.4.3 RISING COMPETITION BETWEEN MARKET PLAYERS 70

9 IMPACT OF COVID-19 ON THE GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET 71

  • 9.1 IMPACT ON PRICE 71
  • 9.2 IMPACT ON DEMAND 71
  • 9.3 IMPACT ON SUPPLY CHAIN 72
  • 9.4 STRATEGIC DECISIONS BY MANUFACTURERS 72
  • 9.5 CONCLUSION 73

10 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE 74

  • 10.1 OVERVIEW 75
  • 10.2 ASSAY KIT 78
    • 10.2.1 T-CELL ASSAY 78
    • 10.2.2 B-CELL ASSAY 78
  • 10.3 SUPPLEMENTARY/ANCILLARY PRODUCTS 78
  • 10.4 ANALYZERS 79

11 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE 80

  • 11.1 OVERVIEW 81
  • 11.2 HUMAN 84
  • 11.3 MOUSE 84
  • 11.4 MONKEY 85
  • 11.5 OTHERS 85

12 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE 86

  • 12.1 OVERVIEW 87
  • 12.2 INFECTIOUS DISEASE 90
    • 12.2.1 INFLUENZA 90
    • 12.2.2 HIV 90
    • 12.2.3 COVID-19 90
    • 12.2.4 OTHERS 90
  • 12.3 CANCER 91
  • 12.4 AUTOIMMUNE DISEASE 91
  • 12.5 ALLERGY 92
  • 12.6 OTHER 92

13 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION 93

  • 13.1 OVERVIEW 94
  • 13.2 DIAGNOSTIC APPLICATION 97
    • 13.2.1 INFECTIOUS DISEASES 97
    • 13.2.2 TRANSPLANTS 97
    • 13.2.3 OTHERS 97
  • 13.3 RESEARCH APPLICATION 98
    • 13.3.1 CLINICAL TRIALS 98
    • 13.3.2 CANCER RESEARCH 98
    • 13.3.3 VACCINE DEVELOPMENT 98
    • 13.3.4 OTHERS 99

14 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER 100

  • 14.1 OVERVIEW 101
  • 14.2 HOSPITALS & CLINICAL LABORATORIES 104
  • 14.3 RESEARCH INSTITUTES 104
  • 14.4 BIOPHARMACEUTICAL COMPANIES 105
  • 14.5 OTHERS 105

15 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION CHANNEL 106

  • 15.1 OVERVIEW 107
  • 15.2 RETAIL SALES 110
  • 15.3 DIRECT TENDER 110

16 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION 111

  • 16.1 OVERVIEW 112
  • 16.2 NORTH AMERICA 117
    • 16.2.1 U.S. 123
    • 16.2.2 CANADA 126
    • 16.2.3 MEXICO 129
  • 16.3 SOUTH AMERICA 132
    • 16.3.1 BRAZIL 138
    • 16.3.2 ARGENTINA 141
    • 16.3.3 REST OF SOUTH AMERICA 144
  • 16.4 MIDDLE EAST AND AFRICA 145
    • 16.4.1 SOUTH AFRICA 151
    • 16.4.2 SAUDI ARABIA 154
    • 16.4.3 U.A.E 157
    • 16.4.4 ISRAEL 160
    • 16.4.5 EGYPT 163
    • 16.4.6 REST OF MIDDLE EAST AND AFRICA 166
  • 16.5 ASIA-PACIFIC 167
    • 16.5.1 CHINA 174
    • 16.5.2 JAPAN 177
    • 16.5.3 INDIA 180
    • 16.5.4 AUSTRALIA 183
    • 16.5.5 SOUTH KOREA 186
    • 16.5.6 SINGAPORE 190
    • 16.5.7 MALAYSIA 193
    • 16.5.8 THAILAND 196
    • 16.5.9 INDONESIA 199
    • 16.5.10 PHILIPPINES 202
    • 16.5.11 REST OF ASIA-PACIFIC 205
  • 16.6 EUROPE 206
    • 16.6.1 GERMANY 213
    • 16.6.2 U.K. 216
    • 16.6.3 FRANCE 219
    • 16.6.4 ITALY 222
    • 16.6.5 SPAIN 225
    • 16.6.6 NETHERLANDS 228
    • 16.6.7 SWITZERLAND 231
    • 16.6.8 RUSSIA 234
    • 16.6.9 BELGIUM 237
    • 16.6.10 TURKEY 240
    • 16.6.11 REST OF EUROPE 243

17 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY LANDSCAPE 244

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL 244
  • 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 245
  • 17.3 COMPANY SHARE ANALYSIS: EUROPE 246
  • 17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 247

18 SWOT ANALYSIS 248

19 COMPANY PROFILE 249

  • 19.1 BD 249
    • 19.1.1 COMPANY SNAPSHOT 249
    • 19.1.2 REVENUE ANALYSIS 249
    • 19.1.3 COMPANY SHARE ANALYSIS 250
    • 19.1.4 PRODUCT PORTFOLIO 250
    • 19.1.5 RECENT DEVELOPMENTS 250
  • 19.2 OXFORD IMMUNOTEC USA, INC. (A SUBSIDIARY OF PERKINELMER INC.) 252
    • 19.2.1 COMPANY SNAPSHOT 252
    • 19.2.2 REVENUE ANALYSIS 252
    • 19.2.3 COMPANY SHARE ANALYSIS 253
    • 19.2.4 PRODUCT PORTFOLIO 253
    • 19.2.5 RECENT DEVELOPMENTS 253
  • 19.3 R&D SYSTEMS, INC. 255
    • 19.3.1 COMPANY SNAPSHOT 255
    • 19.3.2 REVENUE ANALYSIS 255
    • 19.3.3 COMPANY SHARE ANALYSIS 256
    • 19.3.4 PRODUCT PORTFOLIO 256
    • 19.3.5 RECENT DEVELOPMENTS 257
  • 19.4 MABTECH 258
    • 19.4.1 COMPANY SNAPSHOT 258
    • 19.4.2 COMPANY SHARE ANALYSIS 258
    • 19.4.3 PRODUCT PORTFOLIO 258
    • 19.4.4 RECENT DEVELOPMENTS 259
  • 19.5 THERMO FISHER SCIENTIFIC INC. 261
    • 19.5.1 COMPANY SNAPSHOT 261
    • 19.5.2 REVENUE ANALYSIS 261
    • 19.5.3 COMPANY SHARE ANALYSIS 262
    • 19.5.4 PRODUCT PORTFOLIO 262
    • 19.5.5 RECENT DEVELOPMENTS 263
  • 19.6 ABCAM PLC 264
    • 19.6.1 COMPANY SNAPSHOT 264
    • 19.6.2 REVENUE ANALYSIS 264
    • 19.6.3 PRODUCT PORTFOLIO 265
    • 19.6.4 RECENT DEVELOPMENTS 266
  • 19.7 AUTOIMMUN DIAGNOSTIKA GMBH 267
    • 19.7.1 COMPANY SNAPSHOT 267
    • 19.7.2 PRODUCT PORTFOLIO 267
    • 19.7.3 RECENT DEVELOPMENT 267
  • 19.8 CELLCARTA 268
    • 19.8.1 COMPANY SNAPSHOT 268
    • 19.8.2 PRODUCT PORTFOLIO 268
    • 19.8.3 RECENT DEVELOPMENTS 268
  • 19.9 CELLULAR TECHNOLOGY LIMITED (CTL) 269
    • 19.9.1 COMPANY SNAPSHOT 269
    • 19.9.2 PRODUCT PORTFOLIO 269
    • 19.9.3 RECENT DEVELOPMENT 269
  • 19.10 COVANCE INC. (A SUBSIDIARY OF LABCORP DRUG DEVELOPMENT) 270
    • 19.10.1 COMPANY SNAPSHOT 270
    • 19.10.2 REVENUE ANALYSIS 270
    • 19.10.3 PRODUCT PORTFOLIO 271
    • 19.10.4 RECENT DEVELOPMENT 271
  • 19.11 COVALAB, INC. 272
    • 19.11.1 COMPANY SNAPSHOT 272
    • 19.11.2 PRODUCT PORTFOLIO 272
    • 19.11.3 RECENT DEVELOPMENTS 277
  • 19.12 DIACLONE SAS 279
    • 19.12.1 COMPANY SNAPSHOT 279
    • 19.12.2 PRODUCT PORTFOLIO 279
    • 19.12.3 RECENT DEVELOPMENTS 279
  • 19.13 MIKROGEN GMBH 281
    • 19.13.1 COMPANY SNAPSHOT 281
    • 19.13.2 PRODUCT PORTFOLIO 281
    • 19.13.3 RECENT DEVELOPMENT 281
  • 19.14 OXFORD BIOSYSTEMS LTD. 282
    • 19.14.1 COMPANY SNAPSHOT 282
    • 19.14.2 PRODUCT PORTFOLIO 282
    • 19.14.3 RECENT DEVELOPMENT 282
  • 19.15 U-CYTECH 283
    • 19.15.1 COMPANY SNAPSHOT 283
    • 19.15.2 PRODUCT PORTFOLIO 283
    • 19.15.3 RECENT DEVELOPMENT 287

20 QUESTIONNAIRE 288

21 RELATED REPORTS 292

LIST OF TABLES

  • TABLE 1 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 77
  • TABLE 2 GLOBAL ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 78
  • TABLE 3 GLOBAL ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 78
  • TABLE 4 GLOBAL SUPPLEMENTARY/ANCILLARY PRODUCTS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 79
  • TABLE 5 GLOBAL ANALYZERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 79
  • TABLE 6 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 83
  • TABLE 7 GLOBAL HUMAN IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 84
  • TABLE 8 GLOBAL MOUSE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 84
  • TABLE 9 GLOBAL MONKEY IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 85
  • TABLE 10 GLOBAL OTHERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 85
  • TABLE 11 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 89
  • TABLE 12 GLOBAL INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 90
  • TABLE 13 GLOBAL INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 90
  • TABLE 14 GLOBAL CANCER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 91
  • TABLE 15 GLOBAL AUTOIMMUNE DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 91
  • TABLE 16 GLOBAL ALLERGY IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 92
  • TABLE 17 GLOBAL OTHER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 92
  • TABLE 18 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 96
  • TABLE 19 GLOBAL DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 97
  • TABLE 20 GLOBAL DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 97
  • TABLE 21 GLOBAL RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 98
  • TABLE 22 GLOBAL RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 98
  • TABLE 23 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 103
  • TABLE 24 GLOBAL HOSPITALS & CLINICAL LABORATORIES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 104
  • TABLE 25 GLOBAL RESEARCH INSTITUTES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 104
  • TABLE 26 GLOBAL BIOPHARMACEUTICAL COMPANIES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 105
  • TABLE 27 GLOBAL OTHERS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 105
  • TABLE 28 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 109
  • TABLE 29 GLOBAL RETAIL SALES IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 110
  • TABLE 30 GLOBAL DIRECT TENDER IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 110
  • TABLE 31 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY REGION, 2019-2028 (USD MILLION) 116
  • TABLE 32 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 120
  • TABLE 33 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 120
  • TABLE 34 NORTH AMERICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 120
  • TABLE 35 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 120
  • TABLE 36 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 121
  • TABLE 37 NORTH AMERICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 121
  • TABLE 38 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 121
  • TABLE 39 NORTH AMERICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 121
  • TABLE 40 NORTH AMERICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 122
  • TABLE 41 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 122
  • TABLE 42 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 122
  • TABLE 43 U.S. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 123
  • TABLE 44 U.S. ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 123
  • TABLE 45 U.S. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 123
  • TABLE 46 U.S. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 123
  • TABLE 47 U.S. INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 124
  • TABLE 48 U.S. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 124
  • TABLE 49 U.S. DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 124
  • TABLE 50 U.S. RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 124
  • TABLE 51 U.S. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 125
  • TABLE 52 U.S. ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 125
  • TABLE 53 CANADA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 126
  • TABLE 54 CANADA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 126
  • TABLE 55 CANADA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 126
  • TABLE 56 CANADA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 127
  • TABLE 57 CANADA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 127
  • TABLE 58 CANADA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 127
  • TABLE 59 CANADA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 127
  • TABLE 60 CANADA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 128
  • TABLE 61 CANADA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 128
  • TABLE 62 CANADA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 128
  • TABLE 63 MEXICO ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 129
  • TABLE 64 MEXICO ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 129
  • TABLE 65 MEXICO ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 129
  • TABLE 66 MEXICO ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 129
  • TABLE 67 MEXICO INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 130
  • TABLE 68 MEXICO ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 130
  • TABLE 69 MEXICO DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 130
  • TABLE 70 MEXICO RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 130
  • TABLE 71 MEXICO ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 131
  • TABLE 72 MEXICO ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 131
  • TABLE 73 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 135
  • TABLE 74 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 135
  • TABLE 75 SOUTH AMERICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 135
  • TABLE 76 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 135
  • TABLE 77 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 136
  • TABLE 78 SOUTH AMERICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 136
  • TABLE 79 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 136
  • TABLE 80 SOUTH AMERICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 136
  • TABLE 81 SOUTH AMERICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 137
  • TABLE 82 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 137
  • TABLE 83 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 137
  • TABLE 84 BRAZIL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 138
  • TABLE 85 BRAZIL ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 138
  • TABLE 86 BRAZIL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 138
  • TABLE 87 BRAZIL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 139
  • TABLE 88 BRAZIL INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 139
  • TABLE 89 BRAZIL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 139
  • TABLE 90 BRAZIL DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 139
  • TABLE 91 BRAZIL RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 140
  • TABLE 92 BRAZIL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 140
  • TABLE 93 BRAZIL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 140
  • TABLE 94 ARGENTINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 141
  • TABLE 95 ARGENTINA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 141
  • TABLE 96 ARGENTINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 141
  • TABLE 97 ARGENTINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 142
  • TABLE 98 ARGENTINA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 142
  • TABLE 99 ARGENTINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 142
  • TABLE 100 ARGENTINA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 142
  • TABLE 101 ARGENTINA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 143
  • TABLE 102 ARGENTINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 143
  • TABLE 103 ARGENTINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 143
  • TABLE 104 REST OF SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 144
  • TABLE 105 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 148
  • TABLE 106 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 148
  • TABLE 107 MIDDLE EAST AND AFRICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 148
  • TABLE 108 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 148
  • TABLE 109 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 149
  • TABLE 110 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAYMARKET, BY DISEASE, 2019-2028 (USD MILLION) 149
  • TABLE 111 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 149
  • TABLE 112 MIDDLE EAST AND AFRICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 149
  • TABLE 113 MIDDLE EAST AND AFRICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 150
  • TABLE 114 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 150
  • TABLE 115 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 150
  • TABLE 116 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 151
  • TABLE 117 SOUTH AFRICA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 151
  • TABLE 118 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 151
  • TABLE 119 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 152
  • TABLE 120 SOUTH AFRICA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 152
  • TABLE 121 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 152
  • TABLE 122 SOUTH AFRICA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 152
  • TABLE 123 SOUTH AFRICA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 153
  • TABLE 124 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 153
  • TABLE 125 SOUTH AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 153
  • TABLE 126 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 154
  • TABLE 127 SAUDI ARABIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 154
  • TABLE 128 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 154
  • TABLE 129 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 155
  • TABLE 130 SAUDI ARABIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 155
  • TABLE 131 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 155
  • TABLE 132 SAUDI ARABIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 156
  • TABLE 133 SAUDI ARABIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 156
  • TABLE 134 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 156
  • TABLE 135 SAUDI ARABIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 156
  • TABLE 136 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 157
  • TABLE 137 U.A.E ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 157
  • TABLE 138 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 157
  • TABLE 139 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 157
  • TABLE 140 U.A.E INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 158
  • TABLE 141 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 158
  • TABLE 142 U.A.E DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 158
  • TABLE 143 U.A.E RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 158
  • TABLE 144 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 159
  • TABLE 145 U.A.E ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 159
  • TABLE 146 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 160
  • TABLE 147 ISRAEL ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 160
  • TABLE 148 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 160
  • TABLE 149 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 161
  • TABLE 150 ISRAEL INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 161
  • TABLE 151 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 161
  • TABLE 152 ISRAEL DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 161
  • TABLE 153 ISRAEL RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 162
  • TABLE 154 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 162
  • TABLE 155 ISRAEL ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 162
  • TABLE 156 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 163
  • TABLE 157 EGYPT ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 163
  • TABLE 158 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 163
  • TABLE 159 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 164
  • TABLE 160 EGYPT INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 164
  • TABLE 161 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 164
  • TABLE 162 EGYPT DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 164
  • TABLE 163 EGYPT RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 165
  • TABLE 164 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 165
  • TABLE 165 EGYPT ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 165
  • TABLE 166 REST OF MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 166
  • TABLE 167 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 170
  • TABLE 168 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 170
  • TABLE 169 ASIA-PACIFIC ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 170
  • TABLE 170 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 171
  • TABLE 171 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 171
  • TABLE 172 ASIA-PACIFIC INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 171
  • TABLE 173 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 172
  • TABLE 174 ASIA-PACIFIC DIAGNOSTIC APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 172
  • TABLE 175 ASIA-PACIFIC RESEARCH APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 172
  • TABLE 176 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 172
  • TABLE 177 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 173
  • TABLE 178 CHINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 174
  • TABLE 179 CHINA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 174
  • TABLE 180 CHINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 174
  • TABLE 181 CHINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 175
  • TABLE 182 CHINA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 175
  • TABLE 183 CHINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 175
  • TABLE 184 CHINA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 175
  • TABLE 185 CHINA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 176
  • TABLE 186 CHINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 176
  • TABLE 187 CHINA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 176
  • TABLE 188 JAPAN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 177
  • TABLE 189 JAPAN ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 177
  • TABLE 190 JAPAN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 177
  • TABLE 191 JAPAN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 178
  • TABLE 192 JAPAN INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 178
  • TABLE 193 JAPAN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 178
  • TABLE 194 JAPAN DIAGNOSTIC APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 178
  • TABLE 195 JAPAN RESEARCH APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 179
  • TABLE 196 JAPAN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 179
  • TABLE 197 JAPAN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 179
  • TABLE 198 INDIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 180
  • TABLE 199 INDIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 180
  • TABLE 200 INDIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 180
  • TABLE 201 INDIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 181
  • TABLE 202 INDIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 181
  • TABLE 203 INDIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 181
  • TABLE 204 INDIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 181
  • TABLE 205 INDIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 182
  • TABLE 206 INDIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 182
  • TABLE 207 INDIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 182
  • TABLE 208 AUSTRALIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 183
  • TABLE 209 AUSTRALIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 183
  • TABLE 210 AUSTRALIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 183
  • TABLE 211 AUSTRALIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 184
  • TABLE 212 AUSTRALIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 184
  • TABLE 213 AUSTRALIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 184
  • TABLE 214 AUSTRALIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 185
  • TABLE 215 AUSTRALIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 185
  • TABLE 216 AUSTRALIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 185
  • TABLE 217 AUSTRALIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 185
  • TABLE 218 SOUTH KOREA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 186
  • TABLE 219 SOUTH KOREA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 186
  • TABLE 220 SOUTH KOREA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 186
  • TABLE 221 SOUTH KOREA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 187
  • TABLE 222 SOUTH KOREA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 187
  • TABLE 223 SOUTH KOREA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 187
  • TABLE 224 SOUTH KOREA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 188
  • TABLE 225 SOUTH KOREA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 188
  • TABLE 226 SOUTH KOREA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 188
  • TABLE 227 SOUTH KOREA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 189
  • TABLE 228 SINGAPORE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 190
  • TABLE 229 SINGAPORE ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 190
  • TABLE 230 SINGAPORE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 190
  • TABLE 231 SINGAPORE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 191
  • TABLE 232 SINGAPORE INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 191
  • TABLE 233 SINGAPORE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 191
  • TABLE 234 SINGAPORE DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 191
  • TABLE 235 SINGAPORE RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 192
  • TABLE 236 SINGAPORE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 192
  • TABLE 237 SINGAPORE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 192
  • TABLE 238 MALAYSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 193
  • TABLE 239 MALAYSIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 193
  • TABLE 240 MALAYSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 193
  • TABLE 241 MALAYSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 194
  • TABLE 242 MALAYSIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 194
  • TABLE 243 MALAYSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 194
  • TABLE 244 MALAYSIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 194
  • TABLE 245 MALAYSIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 195
  • TABLE 246 MALAYSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 195
  • TABLE 247 MALAYSIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 195
  • TABLE 248 THAILAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 196
  • TABLE 249 THAILAND ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 196
  • TABLE 250 THAILAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 196
  • TABLE 251 THAILAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 197
  • TABLE 252 THAILAND INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 197
  • TABLE 253 THAILAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 197
  • TABLE 254 THAILAND DIAGNOSTIC APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 197
  • TABLE 255 THAILAND RESEARCH APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 198
  • TABLE 256 THAILAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 198
  • TABLE 257 THAILAND ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 198
  • TABLE 258 INDONESIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 199
  • TABLE 259 INDONESIA ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 199
  • TABLE 260 INDONESIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 199
  • TABLE 261 INDONESIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 200
  • TABLE 262 INDONESIA INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 200
  • TABLE 263 INDONESIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 200
  • TABLE 264 INDONESIA DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 200
  • TABLE 265 INDONESIA RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 201
  • TABLE 266 INDONESIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 201
  • TABLE 267 INDONESIA ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 201
  • TABLE 268 PHILIPPINES ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 202
  • TABLE 269 PHILIPPINES ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 202
  • TABLE 270 PHILIPPINES ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 202
  • TABLE 271 PHILIPPINES ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 203
  • TABLE 272 PHILIPPINES INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 203
  • TABLE 273 PHILIPPINES ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 203
  • TABLE 274 PHILIPPINES DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 203
  • TABLE 275 PHILIPPINES RESEARCH APPLICATIONS IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 204
  • TABLE 276 PHILIPPINES ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 204
  • TABLE 277 PHILIPPINES ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 204
  • TABLE 278 REST OF ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 205
  • TABLE 279 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY COUNTRY, 2019-2028 (USD MILLION) 209
  • TABLE 280 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 209
  • TABLE 281 EUROPE ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 209
  • TABLE 282 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 210
  • TABLE 283 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 210
  • TABLE 284 EUROPE INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 210
  • TABLE 285 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 211
  • TABLE 286 EUROPE DIAGNOSTIC APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 211
  • TABLE 287 EUROPE RESEARCH APPLICATION IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY APPLICATION, 2019-2028 (USD MILLION) 211
  • TABLE 288 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY END USER, 2019-2028 (USD MILLION) 211
  • TABLE 289 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISTRIBUTION, 2019-2028 (USD MILLION) 212
  • TABLE 290 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 213
  • TABLE 291 GERMANY ASSAY KIT IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION) 213
  • TABLE 292 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY SOURCE, 2019-2028 (USD MILLION) 213
  • TABLE 293 GERMANY ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 214
  • TABLE 294 GERMANY INFECTIOUS DISEASE IN ELISPOT AND FLUOROSPOT ASSAY MARKET, BY DISEASE, 2019-2028 (USD MILLION) 214

LIST OF FIGURES

  • FIGURE 1 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: SEGMENTATION 36
  • FIGURE 2 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: DATA TRIANGULATION 39
  • FIGURE 3 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: DROC ANALYSIS 40
  • FIGURE 4 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 41
  • FIGURE 5 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY RESEARCH ANALYSIS 41
  • FIGURE 6 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: INTERVIEW DEMOGRAPHICS 43
  • FIGURE 7 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: DBMR MARKET POSITION GRID 44
  • FIGURE 8 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: MARKET APPLICATION COVERAGE GRID 45
  • FIGURE 9 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: VENDOR SHARE ANALYSIS 46
  • FIGURE 10 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: SEGMENTATION 49
  • FIGURE 11 INCREASED INCIDENCE OF CHRONIC DISEASES AND SURGE IN AWARENESS ABOUT THE TIMELY DIAGNOSIS OF THE DISEASES ARE EXPECTED TO DRIVE THE GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028 50
  • FIGURE 12 ASSAY KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET IN 2021 & 2028 50
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028 51
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR ELISPOT AND FLUOROSPOT ASSAY MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028 52
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET 59
  • FIGURE 16 PREVALENCE OF CHRONIC DISEASES DURING THE COVID-19 PANDEMIC 60
  • FIGURE 17 GLOBAL INCIDENCE OF KAWASAKI SYNDROME PER 100,000 CHILDREN UNDER 5 YEARS OF AGE 61
  • FIGURE 18 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE 61
  • FIGURE 19 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, 2020 75
  • FIGURE 20 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, 2019-2028 (USD MILLION) 76
  • FIGURE 21 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, CAGR (2021-2028) 76
  • FIGURE 22 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE, LIFELINE CURVE 77
  • FIGURE 23 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, 2020 81
  • FIGURE 24 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, 2019-2028 (USD MILLION) 82
  • FIGURE 25 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, CAGR (2021-2028) 82
  • FIGURE 26 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY SOURCE, LIFELINE CURVE 83
  • FIGURE 27 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, 2020 87
  • FIGURE 28 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, 2019-2028 (USD MILLION) 88
  • FIGURE 29 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, CAGR (2021-2028) 88
  • FIGURE 30 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISEASE, LIFELINE CURVE 89
  • FIGURE 31 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, 2020 94
  • FIGURE 32 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, 2019-2028 (USD MILLION) 95
  • FIGURE 33 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, CAGR (2021-2028) 95
  • FIGURE 34 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY APPLICATION, LIFELINE CURVE 96
  • FIGURE 35 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, 2020 101
  • FIGURE 36 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, 2019-2028 (USD MILLION) 102
  • FIGURE 37 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, CAGR (2021-2028) 102
  • FIGURE 38 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY END USER, LIFELINE CURVE 103
  • FIGURE 39 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, 2020 107
  • FIGURE 40 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION) 108
  • FIGURE 41 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028) 108
  • FIGURE 42 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 109
  • FIGURE 43 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020) 113
  • FIGURE 44 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY REGION (2020) 114
  • FIGURE 45 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY REGION (2021 & 2028) 114
  • FIGURE 46 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY REGION (2020 & 2028) 115
  • FIGURE 47 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028) 115
  • FIGURE 48 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020) 117
  • FIGURE 49 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020) 118
  • FIGURE 50 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028) 118
  • FIGURE 51 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028) 119
  • FIGURE 52 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028) 119
  • FIGURE 53 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020) 132
  • FIGURE 54 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020) 133
  • FIGURE 55 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028) 133
  • FIGURE 56 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028) 134
  • FIGURE 57 SOUTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028) 134
  • FIGURE 58 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020) 145
  • FIGURE 59 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020) 146
  • FIGURE 60 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028) 146
  • FIGURE 61 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028) 147
  • FIGURE 62 MIDDLE EAST AND AFRICA ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028) 147
  • FIGURE 63 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020) 167
  • FIGURE 64 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020) 168
  • FIGURE 65 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028) 168
  • FIGURE 66 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028) 169
  • FIGURE 67 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028) 169
  • FIGURE 68 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: SNAPSHOT (2020) 206
  • FIGURE 69 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020) 207
  • FIGURE 70 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2021 & 2028) 207
  • FIGURE 71 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY COUNTRY (2020 & 2028) 208
  • FIGURE 72 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: BY PRODUCT TYPE (2021-2028) 208
  • FIGURE 73 GLOBAL ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY SHARE 2020 (%) 244
  • FIGURE 74 NORTH AMERICA ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY SHARE 2020 (%) 245
  • FIGURE 75 EUROPE ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY SHARE 2020 (%) 246
  • FIGURE 76 ASIA-PACIFIC ELISPOT AND FLUOROSPOT ASSAY MARKET: COMPANY SHARE 2020 (%) 247